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Abstract
The baculovirus expression vector system (BEVS) is becoming the method of choice for
expression of many eukaryotic proteins and protein complexes for biochemical, structural
and pharmaceutical studies. Significant technological advancement has made generation of
recombinant baculoviruses easy, efficient and user-friendly. However, there is a tremen-
dous variability in the amount of proteins made using the BEVS, including different batches
of virus made to express the same proteins. Yet, what influences the overall production of
proteins or protein complexes remains largely unclear. Many downstream applications, par-
ticularly protein structure determination, require purification of large quantities of proteins in
a repetitive manner, calling for a reliable experimental set-up to obtain proteins or protein
complexes of interest consistently. During our investigation of optimizing the expression
of the Mediator Head module, we discovered that the ‘initial infectivity’ was an excellent
indicator of overall production of protein complexes. Further, we show that this initial
infectivity can be mathematically described as a function of multiplicity of infection (MOI),
correlating recombinant protein yield and virus titer. All these findings led us to develop
the Titer Estimation for Quality Control (TEQC) method, which enables researchers to
estimate initial infectivity, titer/MOI values in a simple and affordable way, and to use
these values to quantitatively optimize protein expressions utilizing BEVS in a highly
reproducible fashion.
Introduction
The baculovirus expression vector system (BEVS), introduced about 30 years ago [1–5], has
become an essential tool for expression of many eukaryotic proteins and protein complexes in
insect cells [6–8]. BEVS has been proven powerful for structure determination of membrane
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proteins such as GPCRs [9], AMPA receptor [10], NMDA receptor [11], and channel rhodop-
sin [12], which are inherently difficult to work with, as well as cell surface receptors [13–15].
Moreover, development of the MultiBac system, which is suited for expression of multi-pro-
tein complexes, has opened new avenues for structural studies of multi-protein complexes
[16–21]. Key technological advancements of the BEVS lie in the ease and efficient generation
of recombinant baculoviruses harboring single genes [1, 5], or in case of the MultiBac system,
harboring multiple genes, enabling expression of numerous proteins simultaneously [22–24].
Well-established standard procedures for BEVS allow a streamlined workflow, accounting for
its ease of use and high adaptability to routine laboratory operations for many users. Despite of
all these technological advances to simplify the generation of recombinant baculoviruses,
when it comes to protein expression, the key indicator for optimal expression of proteins
remains elusive. For example, there is no clear answer to the question of whether or not a user
would obtain twice as much protein if twice as much baculovirus is added to the insect cells.
The situation is a marked difference from the bacterial expression system in which key factors
for optimization of protein expression (e.g. IPTG concentration) have been well established
[25].
A lack of clarity regarding optimization of protein expression in BEVS may be attributed to
conflicting results from previous studies [26–32]. In these studies, MOI (Multiplicity Of Infec-
tion: how many infectious units per cell) was considered to be a key indicator for expression of
a model protein, β-galactosidase. While some of these studies showed that varying MOI values
had no significant effects [26–28], others showed high MOI [29, 30] or even low MOI [28, 29,
31, 32] conditions resulted in optimal protein expression. The results of these studies did not
provide a clear answer about the correlation between MOI and protein production. The prob-
lem is a lack of understanding the physiological outcome of MOI values: for example, MOI = 2
means having twice as much virus per cell, but how it affects the cells and how it represents
protein expression levels are uncertain. Even if MOI is a good indicator, classical titer/MOI
measurement methods, such as the plaque assay [33], and the immunohistochemical staining
method (Clontech Inc), are too cumbersome and time-consuming to be practically used for
high-throughput expression studies. Other titer/MOI measurement methods such as qPCR
[34], flow cytometric assays (FCA) [35], measurement of cell diameter change of post-infected
cells [36], and a cell line containing eGFP for titer measurement [37] are less tedious. However,
they require specialized equipment, and setting them up is not trivial. Therefore, these meth-
ods are not practical for many users, whose goal is to produce proteins of their interest and not
to measure MOI per se. Furthermore, the condition at which the titer is measured differs vastly
from that at which protein expression is carried out, prompting a question as to how relevant
such a measurement is for protein production. Taken all together, a simple and affordable
experimental method to quantify and optimize expressions of proteins or protein complexes
using BEVS needs to be established for many end users.
Mediator Head module is an essential sub-complex of the Mediator complex, which plays a
key role in transcription regulation in eukaryotes [38]. We used BEVS to generate the Media-
tor Head module for structural and functional studies [16, 39]. We often encountered the
problem of inconsistency in expression level of the Mediator Head module, which prompted
us to investigate a way to optimize expression of the Mediator Head module. Our research led
us to discover the ‘initial infectivity’ as an excellent indicator of overall production of protein
complexes, and we devised a simple and affordable method to estimate this initial infectivity
without the need for any specialized equipment or setting. Our finding led to the development
of the ‘Titer Estimation for Quality Control’ (TEQC) method, which enables users to quantify
and optimize expression of protein complexes in insect cells, ensuring quality control of pro-
tein expression in the BEVS. We consider our TEQC method as a critical tool to address
TECQ method for optimal expressions of protein complexes using the BEVS
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situations in which (i) there is a need to continuously obtain a large amount of recombinant
proteins or protein complexes, or (ii) multiple proteins or protein complexes need to be gener-
ated in large amounts consistently for biochemical, structural and pharmaceutical studies such
as X-ray crystallography, high-throughput compound screening, as well as structure-based
drug discovery.
Materials and methods
Maintenance of insect cells
Hi5 and Sf9 cells were obtained from Expression Systems (Davis, CA). The cells were main-
tained in ESF921 media (Expression systems) in shaker flasks at 27˚C. Both cells were split to a
density of 0.5 × 106 cells/ml every 3 days.
Construction of baculovirus transfer vectors for expression of multi-
protein complexes
All vectors used in this study are summarized in S1 Table. Construction of the baculovirus
transfer vector for expression of modified Mediator Head module used for our structure deter-
mination was described in [16]. Construction of the baculovirus transfer vector bearing the
genes encoding the yeast Mediator Middle module is as follows: Open reading frames (ORFs)
of genes encoding Med7, Med21, Med9, Med4, Med10, Med19 and Med1, were amplified by
PCR from the yeast (S. cerevisiae) genomic DNA. Med31 with a C-terminal HA and 10xhisti-
dine tag (Med31-HA-10His) was amplified by PCR from pBacPAK9-Med31-HA-10His vector,
which was generated by sub-cloning MED31 gene into BamHI and XhoI sites of pBacPAK9
followed by addition of HA and 10xHis tag sequences by two rounds of QuikChange site-
directed mutagenesis (Agilent Technologies). The PCR products were cloned into SphI and
SmaI sites (MCS1), and BamHI and HindIII sites (MCS2) of the pFL vector using the SLIC
method [40] in the following pair-wise combinations: Med7-Med21, Med9-Med4, Med10-
Med31-HA-10xHis-tag, and pFL-Med19-Med1, yielding pFL-Med7-Med21 (pYT53), pFL-
Med9-Med4 (pYT56), pFL-Med10-Med31-HA-10His (pYT55), and pFL-Med19-Med1
(pYT57), respectively. PmeI and AvrII fragment from pYT53 or pYT55 was sub-cloned into
SpeI and NruI sites of pYT56 or pYT57, yielding pFL-Med4-Med7-Med21-Med9 (pYT87),
and pFL-Med10-Med19-Med1-Med31HAHis (pYT85). Finally, PmeI and AvrII fragment
of pYT87 was sub-cloned into SpeI and NruI vector of pYT85, yielding pFL-Med10-Med4-
Med7-Med21-Med9-Med19-Med1-Med31HA-10His (pYT90).
Construction of the baculovirus transfer vector bearing the genes encoding the subunits of
yeast TFIIF, Tfg1, Tfg2 and Tfg3 is as follows: The C-terminal FLAG and TAP tagged TFG1
gene, yTFG1-FLAG-TAP, was amplified by PCR from pDt/g1g2 vector [41] (gift from Ponti-
celli at State University of New York). ORFs of genes encoding yeast Tfg2 and Tfg3, were
amplified by PCR from the yeast genomic DNA. The PCR products were cloned into SphI and
SmaI sites (MCS1), and BamHI and HindIII sites (MCS2) of the pFL vector using the SLIC
method [40], yielding pFL-Tfg1-TAP-Tfg2 (TI150). The PCR product for Tfg3 was cloned
into BamHI and HindIII sites of pUCDM vector, yielding pUCDM-Tfg3 (pYT154). Fusion of
the pTI150 and pYT154 vectors by Cre recombinase (NEB) yielded a transfer vector (TI153),
containing all 3 genes encoding the yeast TFIIF.
Construction of the baculovirus transfer vector bearing the genes encoding the subunits of
yeast core TFIIH, is as follows: ORFs of genes encoding Tfb5, Rad3, Tfb2, Ssl1, Tbf4 and Tfb1-
10xHis tagged, were amplified by PCR from pBacPAK9 vectors bearing corresponding genes
as described previously [42]. The PCR products were sub-cloned into SphI and SmaI sites
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(MCS1), and BamHI and HindIII sites (MCS2) of pFL, pUCDM, and pSPL vectors in pair-
wise fashion, yielding pFL-Tfb5-Rad3 (TI132), pSPL-Tfb2-Ssl1 (pYT444), and pUCDM-Tfb1-
10His-Tfb4 (pYT465), respectively. Fusion of all three vectors by Cre recombinase (NEB)
yielded a transfer vector (TI419), containing all 5 genes encoding the yeast core TFIIH. Open
reading frames (ORFs) of genes encoding yeast Cycline C (CycC), and CDK8 genes were
amplified from the yeast genomic DNA. DNA sequence encoding 10xhistidine tag was added
to the C-terminus of CycC gene during PCR. The PCR products were cloned into SphI and
SmaI sites (MCS1), and BamHI and HindIII sites (MCS2) of the pUCDM vector using the
SLIC method [40], yielding pUCDM-CycC-10His-CDK8 (pYT379). Fusion of pYT379 vector
and an empty pFL vector by Cre recombinase (NEB) yielded a transfer vector (TI600) for
expression of CDK8-CycC-10xHis complex. Construction of human Taf8-Taf10 expression
vector has been previously described [43].
Virus production and storage
Productions of recombinant baculoviruses in Sf9 cells were performed as described [23]. Liq-
uid viruses were stored at 4˚C. Frozen viruses were generated as described (S1 File: Supple-
mental protocol) [44]. Frozen virus stocks were stored under liquid nitrogen.
Estimation of Multiplicity of Infection (eMOI)
The initial infectivity is defined as the infectivity 24 hours after infection (I24). An estimation
of the initial infectivity is denoted as eI24. The multiplicity of infection (MOI), which is a ratio
of infectious units per cell, can be estimated using the following two equations:
eI24 ¼ 1  
C1   C0
ða   1ÞC0
 
Estimation of MOI = eMOI
eMOI ¼   lnð1   eI24Þ ¼   ln
C1   C0
ða   1ÞC0
 
Where a growth constant, α, is the growth rate of uninfected insect cells in a 24 hours period
determined under the same condition used for protein expression, C0 is an initial cell number,
and C1 is the cell number 24 hours after addition of virus. The detailed procedure for estima-
tion of infectivity and MOI is described in S1 File (Supplemental protocol).
Titer measurement by Expression Systems, Inc
Our liquid viruses were shipped to Expression Systems (Davis, CA) for titer measurement.
Titer measurements were performed via flow cytometric analysis (FCA) for expression of the
baculoviral coat protein gp64 by Expression Systems, Inc as described [35]. The numbers of
gp64 positive cells identified by FCA were used to calculate the infectivity of the baculovirus
expressing the Mediator Head module.
Expression of the multi-protein complexes in the insect cells
200 ml culture of Hi5 cells (1.0 × 106 cells/ml) or Sf9 cells (1.5 × 106 cells/ml) was infected with
the amount of viruses indicated. Infected cells were incubated at 27˚C for 96 hours, and were
harvested by centrifugation, frozen in liquid nitrogen, and stored as a pellet at -80˚C until
future use.
TECQ method for optimal expressions of protein complexes using the BEVS
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Purification of protein complexes
The Mediator Head module was purified as described previously [45]. The yeast Mediator
Middle module, core TFIIH, CycC-CDK8, and human Taf8-Taf10, complexes were purified
following the same protocol as well. Briefly, the cells from 200 ml culture were lysed in 50 ml
of lysis buffer: 50 mM Hepes-KOH pH7.6, 400 mM potassium chloride, 10% Glycerol, and 5
mM β-mercaptoethanol, and 0.5 ml of 100 x protease inhibitor mix (6 mM leupeptin, 0.2 mM
pepstatin A, 20 mM benzamidine, and 10 mM PMSF). Cell lysate was stirred for 30 min at 4˚C
followed by centrifugation at 100,000 g for 30 min at 4˚C. The supernatant was loaded onto
0.5 ml of Ni-NTA (HIS-Select, Sigma-Aldrich). The resin was washed with 20 ml of the high
salt buffer (50 mM Hepes-KOH pH7.6, 1 M potassium chloride, 10% Glycerol, 20 mM Imidaz-
ole, and 5 mM β-mercaptoethanol) followed by 5 ml of the low salt buffer (50 mM Hepes-
KOH pH7.6, 100 mM potassium acetate, 10% Glycerol, 20 mM Imidazole, and 5 mM β-mer-
captoethanol). Protein complexes were eluted from Ni-resin with the elution buffer (50 mM
Hepes-KOH pH7.6, 100 mM potassium acetate, 10% Glycerol, 300 mM Imidazole, and 5 mM
β-mercaptoethanol). The recombinant yeast TFIIF complex was purified via an IgG affinity
column. Lysate from 200 ml culture prepared as described above, was loaded onto 0.5 ml of
IgG resin (GE Healthcare). After wash with the high salt and low salt buffer, the recombinant
yeast TFIIF was recovered by TEV protease digestion for 1 hour at room temperature. Con-
centrations of purified protein complexes were measured by Bradford assay.
Assay for solubility of the Head module subunits by quantitative western
blotting
Cells infected with the various eMOIs were expressed in 50 ml culture of Hi5 cells (1.0 × 106
cells/ml), following the same experimental procedure described above. Cells were harvested in
1.5 ml tubes, cell pellets were frozen in liquid nitrogen, and stored at -80˚C until use. Cell pel-
lets were thawed and were resuspended in 100 μl lysis buffer. Lysates were centrifuged at
15,000 rpm for 10 minutes, at 4˚C: supernatant and pellet were separated. Supernatants were
mixed with 30 μl of 4x NuPAGE loading buffer (Life Technologies). Pellets were mixed with
120 μl of 1.5 × NuPAGE loading buffer and solubilized by brief sonication. Samples were sub-
jected to 4–12% NuPAGE (Invitrogen), transferred to PROTRAN membranes (Schleicher &
Schuell), and probed for the Head module with anti–His tag monoclonal antibody (Thermo
Scientific Pierce) for 10xHis-tagged Med17, anti-Med18 (anti-Srb5), and anti-Med11[46].
Detection was carried out using Dylight 680 goat anti–rabbit IgG (Thermo Scientific Pierce)
for Med18 and Med11, and Dylight 800 goat anti-mouse IgG (Thermo Scientific Pierce) for
10-His tag on Med17 and scanning with an Odyssey infrared imaging system (LI-COR Biosci-
ences). Bands were quantified using ImageJ software package [47]. 9 pmol (2 μg) of the puri-
fied Mediator Head module was used as standard.
Results and discussion
The initial infectivity strongly correlates with overall protein complex
production
In our previous work, we used the MultiBac baculovirus expression system as our method of
choice for high-yield, recombinant protein production [16]: As illustrated in Fig 1A, the multi-
gene construct harboring all 7 genes encoding the Mediator Head subunits was generated, and
integrated into baculovirus genome (DH10MultiBac) followed by virus production, expression
and purification of the complex [16] (Fig 1A). We often encountered variability in production
of the Mediator Head module when switching from one batch of baculovirus to the other,
TECQ method for optimal expressions of protein complexes using the BEVS
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Fig 1. Discrepancy in expression levels of the Mediator Head module was observed when using two different
batches of the recombinant baculoviruses, prompting our investigation to seek a key indicator. (A) Schematic
diagram of the workflow of the MultiBac baculovirus expression vector system (BEVS) for expression of the Mediator
Head module. The single transfer vector harboring genes encoding subunits of the Mediator Head module was
integrated into a baculovirus gene followed by virus production, expression and purification of the complex (top).
SDS-PAGE of purified Mediator Head module is shown (bottom on right). The structure using the recombinant Head
module was determined by X-ray crystallography (PDBID: 3RJ1) (bottom on left). Med17 (blue), Med11 (purple),
Med22 (green), Med6 (yellow), Med8 (red), Med18 (cyan), and Med 20 (orange) with electron density map (light
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ranging from 3 mg per 1 L culture to 6 mg per 1 L culture (see below). As described in the
introduction, given a lack of clarity regarding optimization of protein expression in BEVS, we
were prompted to investigate what key factor, if any, is influencing expression of the Mediator
Head module. We compared two different batches of baculoviruses harboring the genes for
expression of the Mediator Head module: batch MB33 and batch MB88, which exhibited dif-
ferent expression levels: 4.3 mg per 1 L culture from batch MB33, and 6.4 mg per 1 L culture
from batch MB88 (Fig 1B). We closely monitored both cell cultures every 24 hours by inspect-
ing cell density and cell morphology. Typically, 24 hours after addition of baculovirus, there
was already a marked difference between the two batches: as for batch MB88, the cell density
was almost the same as the original cell density of 1.0 x 106 cells/ml, indicating growth arrest
(Fig 1C). In addition, the majority of the cells showed rounded cell morphology, slightly
increased overall size, as well as expansion of the nucleus, indicative of viral infection. The
infectivity of batch MB88 at 24 hours appeared to be 100%. In contrast, after 24 hours the cells
infected with batch MB33 virus had a cell density of 1.9 x 106 cells/ml, almost double of the ini-
tial cell density. Roughly 50% of cells appeared to be infected judged by their morphologies.
The trend continued over the next time points, cells infected with batch MB88 showing 100%
infectivity after 24h, remained unchanged in their cell density until the end of the incubation
(Fig 1C). In contrast, infection with batch MB33 virus was incomplete after 24 hours, and
uninfected cells continued to divide until 48 hours (Fig 1C), resulting in a noticeable difference
in amount of the cells being harvested (illustrated in Fig 1B below). In short, the discrepancy
in the overall expression levels of the Mediator Head module correlates with a difference in ini-
tial infectivity of the two batches of virus. Therefore, we hypothesize that the initial infectivity
of the baculovirus, which we define here as infectivity 24 hours after virus addition: I24, could
be an excellent indicator of an overall production of the Mediator Head module.
To test our hypothesis, we pursued to develop a new and simple approach to determine ini-
tial infectivitiy (I24) in order to examine the correlation between initial infectivities and expres-
sion levels of the Mediator Head module in-depth. Technically, flow cytometric assays [35], or
the measurement of cell diameter change of post infected cells using Vi-CELL XR Cell Counter
(Beckman Coulter) [36], could be used to measure an initial infectivity (I24). However, as men-
tioned above, our goal was to devise an easy and affordable experimental method without the
use of specialized equipment and setting so that many end users can utilize it. We reasoned
that an initial infectivity (I24) could be “estimated” by measuring cell densities: C0 (number of
cells per ml) being the initial cell density and C1 being the cell density at 24 hours after addition
of virus, based on the assumption that (i) infected cells lead to immediate growth arrest [48],
resulting in no cell division, and that (ii) uninfected cells divide with a growth constant, α in
24 hours: α indicates how much fold change of uninfected cell growth for a 24 hours period
under the same culture condition used for protein expression, and it is defined as a ratio of cell
densities at the time t and at the time, (t+24 hours): α = cell density at (t+24)/cell density at t.
For example, α = 2 means that cell number doubles in every 24 hours. For accuracy, we mea-
sured α at the same time when I24 was measured by setting up a culture with no virus added.
We like to emphasize at this point, that we were not detecting the number of infected cells
directly. Rather we attempted to estimate how many cells are infected based on the conse-
quence of virus infection (infected cells led to cell arrest). Thus, we designate this value as esti-
mate of I24: eI24. Based on the assumption, the cell density at 24 hours after addition of virus,
pink) (B) Quantity of purified Mediator Head Module varies notably for different batches of the expression
baculovirus (top). Batch MB33 in red and MB88 in dark blue (C) Time course for cell density infected by batch MB33
and batch MB88 viruses during expression from time 0 to up to 96 hours.
https://doi.org/10.1371/journal.pone.0195356.g001
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C1 can be described as a sum of (i) the number of infected cells (C0 × eI24) and (ii) the number
of the uninfected cells that were divided [(C0 − C0 × eI24) × α]: C1 = C0 × eI24 + (C0 − C0 × eI24)
× α. Therefore, eI24 can be described as follows:
eI24 ¼ 1  
C1   C0
ða   1ÞC0
 
ðEq 1Þ
We evaluated if our new method provides estimates of infectivity, that are in line with those
measured by commercially available FCA [35]. In this assay, Sf9 cells were infected by serially
10-fold diluted virus stock, and after 24 hours, the number of viral protein gp64 expressing
cells were identified by flow cytometry. The initial infectivity can be determined by calculating
the ratio between the number of gp64 expressing cells and total number of cells. In parallel, we
set up our measurements using Sf9 cells under equivalent conditions in terms of the ratio
between virus amount and cell number. The cell densities were measured and the initial infec-
tivity for each virus amount was calculated using our formula (Eq 1). Clearly, both methods
are in good agreement for assessing the initial infectivity at almost all dilution points (Fig 2A),
pointing to validity of our newly developed method.
With this new simple method in hands, we set up a series of the insect cell cultures with dif-
ferent amounts of the baculovirus expressing the Mediator Head module. Using our formula
(Eq 1), we calculated eI24 for each culture and plotted those values against protein yield of the
Head module purified from each culture (Fig 2B). In this experiment, infected cells were incu-
bated for 96 hours (our default setting). As shown in Fig 2B, there is a clear correlation
between estimated initial infectivity (eI24), and protein amount of the Mediator Head module:
the Mediator Head module yield increases nearly proportionately to an increase in the value of
eI24 until it reaches close to 100%. Furthermore, we examined the correlation between eI24 and
the protein complex yield when infected cells were incubated for a shorter time (48 and 72
hours) (Fig 2C). The length of incubation period influenced total yield of the complex. How-
ever, it did not influence the overall pattern of correlation between eI24 and yield (Fig 2C).
Taken together, these data supports our hypothesis that our estimated initial infectivity, eI24,
could be a good indicator of the overall Mediator Head module expression in insect cells. The
significance of this finding is that despite the complexity of expressing seven proteins simulta-
neously, the overall protein yield could be influenced by a ‘single’ factor, an initial infectivity,
which can be easily estimated by counting cell density using a hemocytometer or cell counter.
Initial infectivity (I24) of a recombinant baculovirus can be mathematically
described as a function of multiplicity of infection (MOI), connecting MOI
or titer to overall protein complex production
We attempted to mathematically describe initial infectivity, I24, as a function of MOI by apply-
ing the mathematical formula first presented by Ellis and Delbruck in 1939 [49]: A virus infec-
tion is a stochastic event and the probability that number (n) of virus particles infected a cell
with a given multiplicity of infection (MOI) can be approximated using Poisson distribution
[49],
P nð Þ ¼ MOInx
e  MOI
n!
where P (n) is the probability that an insect cell will get infected by number (n) of infectious
units—baculoviruses. This equation is particularly applicable to our case since an initial infec-
tivity (I24) was determined by a primary infection and is not influenced by secondary or ter-
tiary infections. Infectivity as the average percentage of the insect cells that will become
TECQ method for optimal expressions of protein complexes using the BEVS
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infected after addition of baculovirus with a given MOI can be described as:
Infectivity ¼ Pðn > 0Þ ¼ 1   Pð0Þ and Pð0Þ ¼ e  MOI
Therefore, initial infectivity (I24) can be described as a function of multiplicity of infection
(MOI) as follows:
I24 ¼ 1   e
  MOI ðEq 2Þ
Key findings of this equation are two fold: first, a relationship between I24 and MOI is nonlin-
ear (Fig 2D); and second, more importantly, this equation links MOI directly to overall level of
protein expression. Realizing this mathematical relationship between MOI and overall protein
Fig 2. Infectivity of insect cells 24 hours after addition of virus could serve as a good indicator for the expression level of the
Mediator Head module. (A) Comparison between the initial infectivity estimates (eI24) derived from the cell density measurement
based method and I24 (FCA) from flow cytometric assay (FCA). Sf9 cells were infected with 10-fold serially diluted recombinant
baculovirus expressing the Mediator Head module as indicted in Fig 2A. 24 hours after addition of the virus, infectivity of each
dilution point was determined by our cell density measurement based method as well as by FCA (Expression Systems Inc.) in which
the percentage of gp64 expressing cells was calculated. X-axis: Virus volume/ total cell number (Vvirus/cell x 5.0 x10
-5); Y-axis: initial
infectivity (%). eI24 are shown in dark blue and FCA I24 are shown in green. (B) Initial infectivity (I24) vs. yield of the Mediator Head
Module. A total of 8 x 200 ml cultures were infected by various amounts of the baculovirus harboring the genes that encode the
Mediator Head module. SDS-PAGE of purified Mediator Head module in eight different infectivity conditions is displayed on the
right. The protein complex yield from each condition was measured and plotted against eight different infectivities on the left. The
estimated infectivity was ranging from 45% to 98.1%. The cell culture conditions of batch MB33 and batch MB88 were superimposed
onto Fig 2B indicated by red closed circles and red arrows. (C) Correlation between eI24 and the protein complex yield when infected
cells were incubated for 48, 72, and 96 hours. A total of 5 x 200 ml cultures were infected by various amounts of the baculovirus
harboring the genes that encode the Mediator Head module, and incubated for shorter time periods (48 and 72 hours). The protein
complex yield at each infectivity from the culture incubated for 48 or 72 hours was measured, and plotted against five different
infectivities. The data from the culture incubated for 96 hours shown in Fig 2B, was superimposed in the same plot. (D) Relationship
between infectivity and MOI. Non-linear nature of mathematical relationship between infectivity and multiplicity of infection (MOI)
is displayed as table on the left and graph on the right. (E) eMOI vs. yield of the Mediator Head Module. Yield of the Mediator Head
Module was plotted against eMOI, which was calculated from eI24 values using Eq 4. The cell culture conditions of batch MB33, and
batch MB88 were superimposed onto Fig 2E, indicated by red closed circles and red arrows.
https://doi.org/10.1371/journal.pone.0195356.g002
TECQ method for optimal expressions of protein complexes using the BEVS
PLOS ONE | https://doi.org/10.1371/journal.pone.0195356 April 3, 2018 9 / 21
complex expression level is key discovery in this work.
We assume that Iestimate ðeI24Þ ¼ 1   e
  MOI estimate: ðEq 3Þ
By combining Eqs 1 and 3, I24 estimate = eI24, and MOI estimate (eMOI) can be described as
follows:
eMOI ¼   lnð1   eI24Þ ¼   ln
C1   C0
ða   1ÞC0
 
ðEq 4Þ
Since MOI = titer/ cell density x cell culture volume (Vc) x virus volume (Vvirus), then titer esti-
mate, eTiter, can be described as follows:
eTiter ¼
eMOI  C0  Vcell
Vvirus
; ðEq 5Þ
where Vvirus is a virus volume added to the insect cell culture.
We empirically tested our mathematical formula by utilizing the batch MB33 and batch
MB88 viruses, which resulted in different Head module expression levels when infected with
an equal volume of virus. The eI24 and the corresponding eMOI values of batch MB33 and
batch MB88 were determined to be: eI24 (batch MB33) = 0.51 (51%), eMOI (batch MB33) =
1.32, and I24 (Batch MB88) = 0.90 (90%), eMOI (batch MB88) = 3.1, respectively. Numbers of
batch MB33, and batch MB88 and their Head module yields are nicely superimposed on the
plot as a function of eI24 (Fig 2B), as well as that of eMOI (Fig 2E), indicating the validity of
our mathematical formula.
Our results so far led us to hypothesize the following as illustrated in Fig 3: first, a single fac-
tor, the initial infectivity (I24) is a good indicator of overall protein complex expression level as
is MOI despite of complexity of multiple proteins being expressed; second, the relationship
between I24 and MOI is nonlinear (Fig 2D); third, I24 could be estimated simply by measuring
cell density 24 hours after addition of baculovirus with Eq 1; fourth, baculovirus “titer” can be
estimated using Eq 5; and finally and most importantly, using eI24 or eMOI value of a given
virus harboring multiple genes, expression of a protein complex can be quantified and thus,
optimized (Fig 3).
The cell density measurement based method provides estimations of titer
values that are in line with those measured by other titer measurement
method
Our findings so far were very encouraging in terms of developing a simple and affordable
method to estimate viral titer, MOI and infectivity. It will allow us the quality control of pro-
tein complex production using the BEVS in insect cells at very early stages of the experiment.
Moreover, the results from our cell density measurement based method are in good agreement
Fig 3. Schematic diagram for our hypothesis illustrating the mathematical relationship among protein
production, eI24, eMOI, and eTiter. The relationship among protein production, eI24, eMOI, and eTiter was
displayed as schematic diagram.
https://doi.org/10.1371/journal.pone.0195356.g003
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with those from FCA method for assessing the initial infectivity of the baculovirus expressing
the Mediator Head module. We further evaluated whether our new method can also provide
titer estimates that are in line with those measured by one of the conventional titer measure-
ment assays. To this end, we compared titer values obtained from our formula (Eq 5) (Fig 3) to
those from commercially available flow cytometric assay based titer measurements, which pro-
vides titer values, that are in good correlation with those obtained by plaque assay [35]. Titers
of a total of twelve baculoviruses were measured by both methods and compared (Fig 4A and
4B). Six of these viruses do not contain any particular gene and consist of the control virus
with known titer [1.0 x 109 Infectious Unit (IU) /ml] purchased from Expression Systems, Inc
(Davis, CA), baculovirus generated from bacmid alone (DH10MultiBac) (S1A Fig) [23], eYFP
containing bacmid [50] (S1B Fig), bacmids fused with several empty MultiBac transfer vectors,
one vector (pFL) labeled as Vec1, (S1C Fig), two vectors (pFL+pUCDM) labeled as Vec2, (S1D
Fig), or three vectors (pFL+pUCDM+pSPL) labeled as Vec3, ((Fig 4A, S1E Fig). The other six
baculoviruses contain genes for the protein complexes, which include the Mediator Head
module, yeast TFIIF, human Taf8-Taf10 heterodimer, yeast CycC-CDK8 complex, yeast core
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Fig 4. Comparison of titer values by the cell density measurement based method vs. commercially available FCA
based titer measurement. (A) Titer values were obtained from the cell density measurement based method and
commercially available flow cytometric assay (FCA) based titer measurement for a total of twelve baculoviruses, and
these values were compared. All measurements were performed in Sf9 cells. Titers of the control virus with known titer
(1.0 x 109 IU/ml) purchased from Expression Systems, baculoviruses generated from bacmid alone [23], eYFP
containing bacmid [50], bacmids fused with several empty Multibac transfer vectors, respectively. Each measurement
was repeated three times and averaged except for the control virus. eTiters are shown in dark blue and FCA titers are
shown in green. (B) Comparison between eTiter and FCA titer. Titers of recombinant baculoviruses for the yeast
Mediator Head module, yeast TFIIF, human Taf8-Taf10 heterodimer, yeast CycC-CDK8 complex, yeast core TFIIH,
and the yeast Mediator Middle module were measured by two different methods and compared. Each measurement
was repeated three times and averaged. eTiters are shown in dark blue and FCA titers are shown in green. (C) Different
insect cell lines yield different eTiter values. The eTiters for a total of 12 viruses were measured in both Sf9 and Hi5
cells and compared. The eTiters in Sf9 are colored in dark blue, and those in Hi5 are colored in orange.
https://doi.org/10.1371/journal.pone.0195356.g004
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TFIIH, and the Mediator Middle module, respectively (Fig 4B). As described in S1 File, we
derived eTiter values from four different data points of different virus volumes using linear
regression: Each measurement was repeated three times and averaged (S2 and S3 Figs). Com-
paring both methods for the viruses expressing protein complexes, the obtained titer values
are in good agreement for five out of six viruses (Fig 4B). The other viruses, which do not con-
tain genes for recombinant protein expression, and the one encoding the yeast core TFIIH
genes titer values measured using our formula (Eq 5) are on average 2.1 times higher than
those determined by the FCA method. In this regard, there are several other studies published
comparing different titer measurement methods. For example, a 2–3 fold difference between
the end-point dilution assay, and qPCR based assay was observed [51]; the analysis of end
point dilution using GFP and anti-DBP (DNA Binding Protein) based assay showed as much
as a 15-fold difference between the titer values [52]. Compared to these previous results,
clearly, our measurement results are in a reasonable and acceptable range. Therefore, we con-
clude that our formula provides good titer estimations and thus, can be extended in its applica-
tion to aid in the robust expression of many proteins.
As suggested, titer values can be dependent upon medium and cell types [35]. To address
this, we tested if there is a difference in eTiter values between Sf9 cells and Hi5 cells. Since the
FCA titer measurement service is available in only Sf9 cells, but not in Hi5 cells, we used our
method to measure eTiter values of all twelve viruses described above using Hi5 cells and com-
pared them to Sf9 cells (Fig 4C, S4 Fig). Although eTiter values of the control virus are similar
in both cell lines, eTiter values of the other eleven MultiBac based viruses measured in Hi5
cells are approximately twice as high than those measured in Sf9 cells.
The condition at which eI24100% (eMOI = 3 or greater), provides the
optimal or near optimal expression levels for a series of protein complexes
involved in eukaryotic transcription by RNA polymerase II
We applied our newly developed method to several other recombinant protein complexes
involved in eukaryotic RNA polymerase II (Pol II) mediated transcription to see if their
expression levels could be quantified and optimized in a similar fashion. Eukaryotic transcrip-
tion by Pol II is driven by a series of multi-protein complexes including the TATA-box protein
associated factors (TAFs), general transcription factors, TFIIH, and TFIIF, Mediator, and
CDK8 module [53–55]. Generation of recombinant forms of these complexes and their sub-
complexes will be essential for structural and functional studies. A set of expression baculo-
viruses for human Taf8-Taf10 complex (2 subunits)[43], yeast core TFIIH (6 subunits), yeast
TFIIF (3 subunits), yeast CDK8-CycC (2 subunits), yeast Mediator Middle module (8 sub-
units), and the yeast Mediator Head module (7 subunits) were generated. Following our proto-
col (S1 File: Supplemental protocol), eI24 value of each virus was determined followed by
calculating eMOI, and eTiter (Fig 5). These complexes were expressed in 8–9 different infec-
tion conditions ranging from 18% infectivity (eMOI = 0.2) to ~100% (eMOI = 3–5) (Fig 5).
Each complex at each infection point was expressed in a 200 ml culture of Sf9 or Hi5 cells fol-
lowed by affinity purification and quantification of the purified complex. The yield of each
protein complex was plotted against eI24. We also used the corresponding eMOI to display
because eMOI is intuitively easy to understand: for instance, eMOI = 2 indicates adding twice
as much volume of virus as eMOI = 1. There is a good correlation between the eI24 of the
expression baculovirus and the overall protein complex production (Fig 5). Protein complex
yield peaked at or near infection saturation point of eMOI being 3 or greater (Fig 5) except for
the case of the Mediator Middle module: its yield peaked at an earlier infectivity point (39.3%;
eMOI = 0.5) (Fig 5A). However, the protein complex yield difference between eMOI = 0.5 and
TECQ method for optimal expressions of protein complexes using the BEVS
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eMOI = 3–5 is relatively small with 10 mg/L and 9 mg/L, respectively, accounting for only a
10% difference. In other words, the eMOI = 3–5 is nearly optimal. Key conclusion is that the
condition at which eI24 = 100% or eMOI3 provides the optimal, or near optimal expression
levels for all cases tested. We call this the “eMOI = 3 or greater” rule. It is not entirely surpris-
ing to see that optimal protein expression is observed when cells are fully infected within the
first 24 hours, considering a delay in infection due to lower virus load consequently postpones
reaching the level of maximum amount of recombinant protein producing cells and ultimately
yield in the given time-frame. Our “eMOI = 3 or greater” captures such condition for an opti-
mal protein production.
We further tested the idea that once the cells are more than 95% infected (eMOI 3), any
additional excess virus would not necessarily increase overall expression level of protein com-
plexes. To test this idea, the Mediator Head module, hTaf8-Taf10 and yeast core TFIIH were
chosen because the Head is our model complex and the other two are on different ends of the
spectrum in size and expression levels: hTaf8-Taf10 is considered a relatively small complex
(81 kDa), and was highly expressed (Fig 5A) while yeast core TFIIH is a relatively large com-
plex (6 subunits, 320 kDa) and not expressed well (Fig 5B). For all three complexes (S5 Fig),
additional excess virus did not improve overall yield of the protein complexes, suggesting that
once the cells are fully infected, further addition of expression virus may not improve overall
expression of protein complexes. During our study, we noticed a marked difference in expres-
sion levels of protein complexes between Hi5 and Sf9 cells. Performance of Hi5 cells exceeded
Sf9 cells in 4 out of 6 complexes (Fig 5A and 5D–5F). For expression of yeast core TFIIH (Fig
5B) and TFIIF (Fig 5C), Sf9 cells performed better than Hi5 cells, suggesting that both cell
lines should be tested to obtain maximum yield of protein complex of interest.
Finally, we tested if an increase in yield of protein complex could be attributed to an
increase in overall expression of the complex or an increase in solubility of the subunits. We
used the Mediator Head module as a test case since it showed most change in its yield between
low and high eMOI (Fig 2D). We compared soluble and insoluble fractions of the Head mod-
ule with different eMOI ranging from eMOI = 0.1 (10% infected initially) to eMOI = 4 (~100%
infected) by immunoblotting using antibodies against Med17, Med18 and Med11 subunits
(S6A–S6C Fig). The ratio between soluble and insoluble fractions of Med17, Med18 and
Med11 appears to stay constant, suggesting that an increase of I24 or eMOI leads to an increase
in overall production of the Mediator Head subunits.
The results of a total of six multi-protein complexes are consistent with our hypothesis that
eI24 (or eMOI) can be an excellent indicator of expression levels of multi-protein complexes.
By varying eI24 or eMOI value, the optimum expression points of all complexes can be identi-
fied. But in the end, the condition at which eI24 = 100% or eMOI3 provides the optimal, or
near optimal expression levels (“eMOI = 3 or greater” rule). In essence, our simple and afford-
able cell density measurement based method provides eI24 or eMOI value of a recombinant
baculovirus. Researchers (end users) can use these values to quantitatively optimize expression
levels of proteins or protein complexes of their interest. We named our newly developed quan-
titative method “TEQC” method: “Titer Estimation for Quality Control” (TEQC) of protein or
protein complex production.
Fig 5. Quantification of expression of the multi-protein complexes involved in eukaryotic RNA polymerase II transcription by varying eI24 or eMOI values
in the Hi5 and Sf9 cells. A total of six different multi-protein complexes were expressed in Hi5 cells and Sf9 cells under different conditions in terms of initial
infectivity (eI24) or eMOI ranging from eI24 = 18% (eMOI = 0.2) to eI24 = 100% (eMOI = 4–5) in a 200 ml culture scale. SDS-PAGE of each purified complex with
different eI24 or eMOI values is shown in right. Yield of complex at each point was measured and plotted against I24 (left) or eMOI (right) panel. The results from
expression using Hi5 cells were shown on top and those from Sf9 cells were shown at the bottom. (A) Human Taf8-Taf10 complex, (B) yeast core TFIIH complex,
(C) yeast TFIIF, (D) yeast CycC-CDK8, (E) the Mediator middle module, and (F) the Mediator Head module. Asterisk (): contaminant.
https://doi.org/10.1371/journal.pone.0195356.g005
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TEQC method can be utilized to achieve reproducible expression of protein
complexes to ensure quality control
We tested whether we could use the eMOI value to achieve reproducible expression of protein
complexes, resulting in a production of the recombinant protein complexes with maximum
yield consistently. The conditions for maximum expression levels of 6 protein complexes are
as follows: in the Hi5 cells, the Mediator Head module peaked at eMOI of 3.7; hTaf8-Taf10 at
eMOI of 3.5, yeast CDK8-CycC at eMOI = 3.5, and Mediator middle module at eMOI = 0.5; in
SF9 cells, yeast core TFIIH at eMOI of 3.0, and yeast TFIIF at eMOI of 3.0 (Fig 5), respectively.
For simplicity, we are referring to eMOI only. All these six protein complexes were expressed
using the same optimum eMOI and cell line but were expressed on different days. These inde-
pendent expressions were repeated three times for all complexes. The yield of each purified
protein complex was measured, the numbers were averaged, and compared to the original
expression level that provided the optimum eMOI value in that cell line. For all tested com-
plexes, the yield of purified protein was highly reproducible (Fig 6A).
One of the BEVS benefits is that once a virus is made, it is stable for a long period of time,
ranging from up to couple of years if stored at 4˚C to much longer time spans for frozen stocks,
allowing it be used for multiple rounds of infections and experiments. Over time though, the
infectivity of the virus decreases. To address the situation in which one would like to use
expression baculovirus that has a declined titer due to prolonged storage at 4˚C, we hypothe-
size as follows: as long as the eI24 or eMOI value is the same, an old virus with declined titer
could maintain the same level of expression of protein complex as when it was newly made. To
test this, we set up expressions of four protein complexes described above with eMOI from 1.0
to 4.0, using the old viruses that had been kept at 4˚C for an extended period of time (8 to 10
months). Their eTiters had been declined as follows: Mediator Head from 7.3 x 108 to 4.0 x 108
(IU/ml), hTaf8-Taf10 1.2 x 109 (IU/ml) from to 6.7 x 108 (IU/ml), core TFIIH from 4.5 x 108 to
3.3 x 108 (IU/ml), and TFIIF from 5.1 x 108 to 3.8 x 108 (IU/ml), respectively. eMOI values
ranging from 1 to 4 were achieved by increasing the volume of each virus to compensate for
the loss of virus titer. The yield of each purified protein complex was measured and compared
to the original expression level (Fig 6B–6E, blue lines) by superimposing the data onto the
plots of the original expression data indicated by red lines (Fig 6B–6E). Overall, when the eI24
or eMOIs were adjusted, the expression level profiles of the protein complexes generated by
the old viruses were similar to those generated by their original viruses (Fig 6B–6E), strongly
suggesting that eI24 or eMOI is the key indicator of expression level of protein complexes.
Conclusions
This work has revealed the connection among initial infectivity, MOI, and overall recombinant
protein production. We developed a simple and affordable cell density measurement based
method to estimate initial infectivity, MOI, and titer, leading toward the development of the
TEQC method for optimization of a production of protein complexes using the BEVS. Key
finding is that optimal or near optimal expression levels are reached when eMOI 3, which
represents our “eMOI = 3 or greater” rule. Since expression of single proteins could be viewed
as “one” subunit multi-protein complex, the TEQC method should be applicable to expression
of single proteins as well. Additionally, expression of a protein complex in insect cells was car-
ried out in this work by infecting a single virus harboring multiple genes encoding the subunits
of the complex, and not by co-infecting multiple viruses. The strategy for optimization of pro-
tein complex expression using the co-infection method will be a future subject of
investigation.
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Supporting information
S1 Fig. Schematic diagram of the bacmids used for the study. (A) Schematic diagram of the
workflow of the DH10MultiBac bacmid. DH10MultiBac contains a LoxP site (purple circle)
and Tn7R and Tn7L sites (red triangle) for the insertion of the protein expression cassette. (B)
DH10MultiBac fused with eYFP vector [3] through LoxP site named eYFP, (C) eYFP bacmid
fused with pFL, (D) eYFP bacmid fused with pFL+pUCDM, (E) eYFP bacmid fused with pFL
+pUCDM+pSPL through Tn7 transposition.
(EPS)
S2 Fig. Estimation of titer values of the control virus, the viruses generated from an empty
bacmid, eYFP-containing bacmid, and three empty transfer vectors using linear regression
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Fig 6. TEQC method ensures production reproducibility of multi-protein complexes. (A) Mediator Head module,
Taf8-Taf10, TFIIH core, TFIIF, CycC-CDK8, and Middle were expressed at their optimum infectivity or eMOI, and
each protein complex yield was measured; labeled as “initial” (dark blue). Expression was repeated three times using
the same eMOI or infectivity value for each complex independently, purified protein complex yields were measured
and the numbers were averaged; labeled as repeats. The repeats (green) were compared with the initial protein
expression optimization results (dark blue). (B-E) Mediator Head, Taf8-Taf10, core TFIIH, and TFIIF complexes were
expressed using freshly made new high titer viruses as well as the old viruses with declined titers. The eTiter values of
both new and old viruses were determined and volume of each old or new virus was adjusted such that the expression
of each complex was carried out at the same eI24 or eMOI. After expression and purification, protein complex yield
was measured, and the data were plotted against either eI24 or eMOI. (B) Mediator Head module was expressed in Hi5
cells (red) (C) Taf8-Taf10 was expressed in Hi5 cells, (D) TFIIH core was expressed in Sf9 cells, (E) TFIIF was
expressed in Sf9 cells, and compared with the initial expression results (blue) and the results from old viruses (red).
https://doi.org/10.1371/journal.pone.0195356.g006
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of 5 different measurement points. Five-fold serial dilutions of each virus solution was added
to 50 ml culture of Sf9 cells (1.5 x 106 cells/ml), and cell density was measured 24 hours after
addition of virus. Number of infectious unit (IU) vs. virus volume was plotted and each titer
value was estimated using linear regression. The measurement was repeated three times for
each virus. (A) The control virus, (B) the virus generated from empty bacmid alone (S1A Fig),
(C) the virus from eYFP containing-bacmid (S1B Fig), (D) Vec1: the bacmid with an empty
pFL vector (S1C Fig), (E) Vec2: the bacmid with empty fused (pFL+pUCDM) vector (S1D
Fig), and (F) Vec3: the bacmid with fused three vectors (pFL+pUCDM+pSPL) (S1E Fig).
(EPS)
S3 Fig. Estimation of titer values of the recombinant baculoviruses expressing the Media-
tor Head module, yeast TFIIF, hTaf8-Taf11, yeast core TFIIH, yeast CycC-CDK8, and the
Mediator Middle module, using linear regression of 5 different measurement points. Five-
fold serial dilutions of each virus solution was added to 50 ml culture of Sf9 cells (1.5 x 106
cells/ml), and cell density was measured 24 hours after addition of virus. Number of infectious
unit (IU) vs. virus volume was plotted and each titer value was estimated using linear regres-
sion. The measurement was repeated three times for each virus. (A) Head: the Mediator Head
module, (B) yeast TFIIF, (C) human TAF8-TAF11, (D) yeast core TFIIH, (E) yeast
CycC-CDK8, and (F) Middle: the Mediator Middle module.
(EPS)
S4 Fig. Estimation of titer values of twelve recombinant baculoviruses measured in Sf9
cells and Hi5 cells, using linear regression of five different measurement points. Five-fold
serial dilutions of each virus solution was added to 50 ml culture of Sf9 cells (1.5 x 106 cells/
ml), or 50 ml culture of Hi5 cells (1.0 x 106 cells/ml), and cell density was measured 24 hours
after addition of virus. Number of infectious unit (IU) vs. virus volume was plotted and each
titer value was estimated using linear regression. (A) The control virus, (B) the virus generated
from empty bacmid alone (S1A Fig), (C) the virus from eYFP containing-bacmid (S1B Fig).
(D) Vec1: the bacmid with an empty pFL vector (S1C Fig), (E) Vec2: the bacmid with empty
fused (pFL+pUCDM) vector (S1D Fig), and (F) Vec3: the bacmid with fused three vectors
(pFL+pUCDM+pSPL) (S1E Fig). (G) Head: the Mediator Head module, (H) yeast TFIIF, (I)
human TAF8-TAF11, (J) yeast core TFIIH, (K) yeast CycC-CDK8, and (L) Middle: the Media-
tor Middle module.
(EPS)
S5 Fig. Quantification of expression of the multi-protein complexes involved in eukaryotic
RNA polymerase II gene expressions. The three multi-protein complexes were expressed in
Hi5 cells under the condition of excess baculoviruses being added with eMOI ranging from 4
to 20. (A) The Mediator Head module, (B) human Taf8-Taf10 complex, and (C) yeast core
TFIIH complex.
(EPS)
S6 Fig. Analysis of soluble vs. insoluble fractions of the Mediator Head module subunits
by quantitative western blotting. (A)-(C) Three Head module subunits, Med17, Med18 and
Med11 were expressed at different I24 or eMOI conditions ranging from 10% to 100%,
(eMOI = 0.1, 0.5, 1, 2, 3, 4). At the end of expression, cells were harvested, lysed, insoluble frac-
tions (P: pellet) and soluble fractions (S: sup) were separated by centrifugation followed by
quantitative westernblotting using anti-His antibody against 10xHis tagged Med17 (A), anti-
Med18 antibody (B), and anti-Med11 antibody (C). Mole of each subunit per lane was calcu-
lated using the signal from 10 pmol (2 μg) of the purified Mediator Head module as standard.
The experiments were repeated 3 times. The data were averaged and standard deviations were
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displayed.
(EPS)
S7 Fig. Estimation of the baculovirus titer by linear regresson. Cell density at each virus vol-
ume was measured, and its corresponding eMOI/eTiter were calculated as summarized on
top. Linear regression is derived from 5 different measurement points and plotted in bottom.
X-axis: virus volume (ml); Y-axis: number of infectious units.
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S1 Table. Plasmids for protein complex expression used in this study.
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